Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W. Tenforde, Wesley H. Self, Katherine Adams, et al.
JAMA (2021) Vol. 326, Iss. 20, pp. 2043-2043
Open Access | Times Cited: 586

Showing 26-50 of 586 citing articles:

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients
Andrew H. Karaba, Xianming Zhu, Tao Liang, et al.
American Journal of Transplantation (2021) Vol. 22, Iss. 4, pp. 1253-1260
Open Access | Times Cited: 98
Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination
Michael Klompas
JAMA (2021) Vol. 326, Iss. 20, pp. 2018-2018
Closed Access | Times Cited: 78
Advances in the design and development of SARS-CoV-2 vaccines
Xue‐Liang Peng, Ji‐Si‐Yu Cheng, Hai‐Lun Gong, et al.
Military Medical Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 66
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
Anne M. Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 44, pp. 1401-1406
Open Access | Times Cited: 66
Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines
J. Daniel Kelly, Samuel Leonard, Katherine J. Hoggatt, et al.
JAMA (2022) Vol. 328, Iss. 14, pp. 1427-1427
Open Access | Times Cited: 59
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Paul Bastard, Sara E. Vazquez, Jamin Liu, et al.
Science Immunology (2022) Vol. 8, Iss. 90
Open Access | Times Cited: 55
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
Marios Koutsakos, Wen Shi Lee, Arnold Reynaldi, et al.
Immunity (2022) Vol. 55, Iss. 7, pp. 1316-1326.e4
Open Access | Times Cited: 53
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study
Kerstin Kläser, Erika Molteni, Mark S. Graham, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
Stephanie J. Schrag, Jennifer R. Verani, Brian E. Dixon, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2233273-e2233273
Open Access | Times Cited: 50
Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress
Jin H. Han, Kelsey N. Womack, Mark W. Tenforde, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 16, Iss. 4, pp. 680-689
Open Access | Times Cited: 49
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients
Robert Whittaker, Anja Bråthen Kristofferson, Beatriz Valcárcel Salamanca, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 6, pp. 871-878
Open Access | Times Cited: 47
Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection
Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
Ralph Rogers, Deborah Wentworth, Andrew Phillips, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 10, pp. 1401-1410
Open Access | Times Cited: 47
COVID-19 Vaccine Challenges in Developing and Developed Countries
Harshani Yarlagadda, Meet Patel, Vasu Gupta, et al.
Cureus (2022)
Open Access | Times Cited: 45
Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
Isaac Yeboah Addo, Frederick Dadzie, Sylvester Reuben Okeke, et al.
Archives of Public Health (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 45
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Laurent Rénia, Yun Shan Goh, Angéline Rouers, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Trends and Risk Factors of In-Hospital Mortality of Patients with COVID-19 in Germany: Results of a Large Nationwide Inpatient Sample
Lukas Hobohm, Ingo Sagoschen, Stefano Barco, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 275-275
Open Access | Times Cited: 41
Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
Mingshuang Li, Qianqian Liu, Dan Wu, et al.
China CDC Weekly (2022) Vol. 4, Iss. 14, pp. 293-297
Open Access | Times Cited: 41
BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5–18 Years—United States, July 2021 – April 2022
Laura D. Zambrano, Margaret M. Newhams, Samantha M. Olson, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e90-e100
Open Access | Times Cited: 38
The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study
Ahmet Naci Emecen, Salih Keskin, Ö Turunç, et al.
Irish Journal of Medical Science (1971 -) (2022) Vol. 192, Iss. 2, pp. 741-750
Open Access | Times Cited: 37
Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force
Ho Lee, Shotaro Chubachi, Ho Namkoong, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 37
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19
Wesley H. Self, Matthew S. Shotwell, Kevin W. Gibbs, et al.
JAMA (2023) Vol. 329, Iss. 14, pp. 1170-1170
Open Access | Times Cited: 29
The Relationship of COVID-19 Vaccination with Mortality Among 86,732 Hospitalized Patients: Subpopulations, Patient Factors, and Changes over Time
Timothy B. Baker, Daniel M. Bolt, Stevens S. Smith, et al.
Journal of General Internal Medicine (2023) Vol. 38, Iss. 5, pp. 1248-1255
Open Access | Times Cited: 28
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022
Noah Kojima, Katherine Adams, Wesley H. Self, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 4, pp. 547-557
Open Access | Times Cited: 26
The impact of the COVID-19 pandemic on parental vaccine hesitancy: A cross-sectional survey
Lily A. Grills, Abram L. Wagner
Vaccine (2023) Vol. 41, Iss. 41, pp. 6127-6133
Open Access | Times Cited: 25

Scroll to top